Author

Darrell Pardi

AN INVESTIGATIONAL ORAL MICROBIOME DRUG, CP101, FOR THE PREVENTION OF RECURRENT C. DIFFICILE INFECTION: A RANDOMIZED, PLACEBO-CONTROLLED, MULTI-CENTER TRIAL (PRISM3)
AN INVESTIGATIONAL ORAL MICROBIOME DRUG, CP101, FOR THE PREVENTION OF RECURRENT C. DIFFICILE INFECTION: A RANDOMIZED, PLACEBO-CONTROLLED, MULTI-CENTER TRIAL (PRISM3)

Darrell Pardi  et al.

MICROSCOPIC COLITIS NO MORE: HLA ASSOCIATION DISCRIMINATES COLLAGENOUS FROM LYMPHOCYTIC COLITIS
MICROSCOPIC COLITIS NO MORE: HLA ASSOCIATION DISCRIMINATES COLLAGENOUS FROM LYMPHOCYTIC COLITIS

Darrell Pardi  et al.

Item 1 - 2 / 2
1